Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 90
Filter
1.
Acta Endocrinol (Buchar) ; 18(2): 174-180, 2022.
Article in English | MEDLINE | ID: mdl-36212268

ABSTRACT

Background: Erectile dysfunction(ED) in men is a frequent under-reported complication of diabetes mellitus, which is becoming significant health problem worldwide. Aims: The study aims to determine the prevalence and risk factors for development of ED in North Indian patients with type 2 diabetes mellitus. Methods: We used international index of erectile function (IIEF-5) for the assessment of ED in 796 patients with type 2 diabetes mellitus. We recorded the age, duration of diabetes, glycemic status, body mass index, diabetes medications, microvascular and macrovascular complications. Results: The mean age of patients in the study was 49.38 ± 9.52 years. The prevalence of ED in patients with type 2 diabetes mellitus was 79.4%. Logistic regression analysis revealed that age, body mass index, glycemic control, insulin therapy, retinopathy and nephropathy was not significantly associated with erectile dysfunction in patients with type 2 diabetes mellitus. Duration of diabetes (OR = 1.054, 95% CI 1.007 to 1.102, P=0.023) and vibration perception threshold (OR = 1.071, 95% CI 1.042 to 1.102, P=0.000) were identified as key risk factors for development of ED. Conclusion: Duration of diabetes and peripheral neuropathy emerged as significant risk factors for development of severe erectile dysfunction.

2.
Eur Arch Paediatr Dent ; 23(3): 465-473, 2022 Jun.
Article in English | MEDLINE | ID: mdl-35380376

ABSTRACT

AIM: To compare the sedation regimen Dexmedetomidine alone and its combination with low dose Ketamine through intravenous route in terms of safety, efficacy and recovery profile in uncooperative paediatric dental patients requiring pulpectomy. MATERIAL AND METHODS: Thirty anxious and uncooperative 2-6-year-old children requiring pulpectomy in at least one primary molar were enrolled. Propofol was used as an induction agent. Drugs were administered through the intravenous route as per group assignment, i.e., Dexmedetomidine (1 µg/kg) with ketamine (0.5 mg/kg) administered over 10 min followed by a maintenance dose of Dexmedetomidine (0.2-0.8 µg/kg/h) in group A and Dexmedetomidine (1 µg/kg) administered over 10 min followed by a maintenance dose in group B. The sedation was titrated to achieve Houpt's overall behavior score of 4/5. The primary outcome measure was the successful completion of treatment. Secondary outcome measures were vital signs, quality of sedation, time need for the procedure, recovery time, intra-operative and post-operative adverse sequelae. RESULTS: Results showed that both of the regimens were similar in efficacy, safety and recovery profile. Also, the required dose of dexmedetomidine and the need for rescue boluses was similar in both of the study groups. CONCLUSION: Dexmedetomidine either alone or in combination with ketamine proved to be a safe and efficacious agent for paediatric dental sedation. No beneficial evidence of adding ketamine was observed.


Subject(s)
Dexmedetomidine , Ketamine , Propofol , Child , Dexmedetomidine/adverse effects , Double-Blind Method , Humans , Hypnotics and Sedatives/adverse effects , Ketamine/adverse effects , Propofol/adverse effects , Pulpectomy
3.
Behav Brain Res ; 381: 112456, 2020 03 02.
Article in English | MEDLINE | ID: mdl-31891743

ABSTRACT

Excessive alcohol (ethanol) consumption negatively impacts social, emotional, as well as cognitive function and well-being. Thus, identifying behavioral and/or biological predictors of excessive ethanol consumption is important for developing prevention and treatment strategies against alcohol use disorders (AUDs). Sex differences in alcohol consumption patterns are observed in humans, primates, and rodents. Selectively bred high alcohol-drinking rat lines, such as the "HAD-1" lines are recognized animal models of alcoholism. The present work examined sex differences in alcohol consumption, object recognition, and exploratory behavior in male and female HAD-1 rats. Naïve male and female HAD-1 rats were tested in an object recognition test (ORT) prior to a chronic 24 h intermittent ethanol access procedure for five weeks. Object recognition parameters measured included exploratory behavior, object investigation, and time spent near objects. During the initial training trial, rearing, active object investigation and amount of time spent in the object-containing section was significantly greater in female HAD-1 rats compared to their male counterparts. During the subsequent testing trial, time spent in the object-containing section was greater in female, compared to male, rats; but active object investigation and rearing did not statistically differ between females and males. In addition, female HAD-1 rats consumed significantly more ethanol than their male counterparts, replicating previous findings. Moreover, across all animals there was a significant positive correlation between exploratory behavior in ORT and ethanol consumption level. These results indicate there are significant sex differences in cognitive performance and alcohol consumption in HAD-1 rats, which suggests neurobiological differences as well.


Subject(s)
Alcohol Drinking/physiopathology , Alcoholism/physiopathology , Cognition/physiology , Exploratory Behavior/physiology , Sex Characteristics , Animals , Central Nervous System Depressants/administration & dosage , Ethanol/administration & dosage , Female , Male , Open Field Test/physiology , Rats , Recognition, Psychology , Self Administration
4.
Physiol Behav ; 203: 81-90, 2019 05 01.
Article in English | MEDLINE | ID: mdl-29146494

ABSTRACT

Ultrasonic vocalizations (USVs) have been established as an animal model of emotional status and are often utilized in drug abuse studies as motivational and emotional indices. Further USV functionality has been demonstrated in our recent work showing accurate identification of selectively-bred high versus low alcohol-consuming male rats ascertained exclusively from 22 to 28kHz and 50-55kHz FM USV acoustic parameters. With the hypothesis that alcohol-sensitive sex differences could be revealed through USV acoustic parameters, the present study examined USVs and alcohol consumption in male and female selectively bred high-alcohol drinking (HAD-1) rats. For the current study, we examined USV data collected during a 12-week experiment in male and female HAD-1 rats. Experimental phases included Baseline (2weeks), 4-h EtOH Access (4weeks), 24-h EtOH Access (4weeks) and Abstinence (2weeks). Findings showed that both male and female HAD-1 rats spontaneously emitted a large number of 22-28kHz and 50-55kHz FM USVs and that females drank significantly more alcohol compared to males over the entire course of the experiment. Analyses of USV acoustic characteristics (i.e. mean frequency, duration, bandwidth and power) revealed distinct sex-specific phenotypes in both 50-55kHz FM and 22-28kHz USV transmission that were modulated by ethanol exposure. Moreover, by using a linear combination of these acoustic characteristics, we were able to develop binomial logistic regression models able to discriminate between male and female HAD-1 rats with high accuracy. Together these results highlight unique emotional phenotypes in male and female HAD-1 rats that are differentially modulated by alcohol experience.


Subject(s)
Alcohol Drinking/genetics , Ethanol/administration & dosage , Motivation/drug effects , Sex Characteristics , Vocalization, Animal/drug effects , Animals , Female , Male , Rats , Ultrasonics
5.
Bone Joint J ; 100-B(8): 1094-1099, 2018 08.
Article in English | MEDLINE | ID: mdl-30062945

ABSTRACT

Aims: The aims of this study were to establish whether composite fixation (rail-plate) decreases fixator time and related problems in the management of patients with infected nonunion of tibia with a segmental defect, without compromising the anatomical and functional outcomes achieved using the classical Ilizarov technique. We also wished to study the acceptability of this technique using patient-based objective criteria. Patients and Methods: Between January 2012 and January 2015, 14 consecutive patients were treated for an infected nonunion of the tibia with a gap and were included in the study. During stage one, a radical debridement of bone and soft tissue was undertaken with the introduction of an antibiotic-loaded cement spacer. At the second stage, the tibia was stabilized using a long lateral locked plate and a six-pin monorail fixator on its anteromedial surface. A corticotomy was performed at the appropriate level. During the third stage, i.e. at the end of the distraction phase, the transported fragment was aligned and fixed to the plate with two to four screws. An iliac crest autograft was added to the docking site and the fixator was removed. Functional outcome was assessed using the Association for the Study and Application of Methods of Ilizarov (ASAMI) criteria. Patient-reported outcomes were assessed using the Musculoskeletal Tumor Society (MSTS) score. Results: The mean age of patients was 38.1 years (sd 12.7). There were 13 men and one woman. The mean size of the defect was 6.4 cm (sd 1.3). the mean follow-up was 33.2 months (24 to 50). The mean external fixator index was 21.2 days/cm (sd 1.5). The complication rate was 0.5 (7/14) per patient. According to the classification of Paley, there were five problems and two obstacles but no true complications. The ASAMI bone score was excellent in all patients. The functional ASAMI scores were excellent in eight and good in six patients. The mean MSTS composite score was 83.9% (sd 7.1), with an MSTS emotional acceptance score of 4.9 (sd 0.5; maximum possible 5). Conclusion: Composite fixation (rail-plate) decreases fixator time and the associated complications, in the treatment of patients of infected nonunion tibia with a segmental defect. It also provides good anatomical and functional results with high emotional acceptance. Cite this article: Bone Joint J 2018;100-B:1094-9.


Subject(s)
Bone Diseases, Infectious/complications , External Fixators , Fractures, Ununited/surgery , Tibial Fractures/surgery , Adult , Bone Plates , Debridement/methods , Female , Fracture Healing/physiology , Fractures, Ununited/complications , Fractures, Ununited/diagnostic imaging , Humans , Ilizarov Technique/instrumentation , Male , Patient Reported Outcome Measures , Patient Satisfaction , Prospective Studies , Radiography , Retrospective Studies , Salvage Therapy/instrumentation , Salvage Therapy/methods , Tibial Fractures/complications , Tibial Fractures/diagnostic imaging
6.
Int J Lab Hematol ; 40(5): 604-610, 2018 Oct.
Article in English | MEDLINE | ID: mdl-29938911

ABSTRACT

INTRODUCTION: There is a paucity of literature related to the prevalence of Paroxysmal Nocturnal haemoglobinuria (PNH) clones in paediatric aplastic anaemia (AA) patients. METHODS: We performed a retrospective analysis over a period of 42 months to study the prevalence of PNH clones in paediatric (age less than 18 years) AA cases, using Fluorescein-labelled proaerolysin-based flow cytometric screening and analysed their clinico-pathological features. RESULTS: PNH clone was identified in 100 (33.2%) of the 301 patients screened. These were comprised of 51 cases of non-severe AA, 33 cases of severe AA and 16 cases of very severe AA. The median age was 13 years with an M:F ratio of 2.5:1. The median clone size (taken as the proportion of PNH-positive neutrophils) was 2.15% (range: 0.05%-93.1%). Although a majority of patients (n = 77) had a clone size of less than 10%, a significant proportion (n = 23) did harbour a clone size of more than 10%. Evidence of haemolysis was observed in 3 patients, all of them having a clone size of more than 10%. Interestingly, 1 patient with dural sinus thrombosis harboured a clone size of 1.25% only. Chromosomal breakage analysis was performed in 61 patients, none of which was positive. Complete and partial response to immunosuppressive therapy was found in 55.1% patients (16/29). CONCLUSION: There is a high prevalence of PNH clones in paediatric AA patients, which in a majority of cases are of small clone sizes. The use of immunosuppressive therapy does not show a better outcome as compared to PNH-negative cases.

8.
Indian J Med Microbiol ; 33(4): 590-3, 2015.
Article in English | MEDLINE | ID: mdl-26470973

ABSTRACT

Cryptococcal meningitis in immunocompetent post-partum women has been rarely reported. Immune restoration during post-partum period leads to unmasking of many opportunistic infections that may have been acquired during pregnancy but manifest itself in the post-partum period due to immune reconstitution inflammatory syndrome. This case highlights the importance of considering opportunistic pathogens in immunocompetent patients who may be undergoing immune restoration. We report here a fatal case of post-partum immunocompetent women who presented with clinical features of meningitis. Prognosis of the cryptococcal meningitis not only depends on the immune status of the patient but also on how early the disease is diagnosed in the course of illness.


Subject(s)
Cryptococcus/isolation & purification , Immune Reconstitution Inflammatory Syndrome/diagnosis , Immune Reconstitution Inflammatory Syndrome/pathology , Meningitis, Cryptococcal/diagnosis , Meningitis, Cryptococcal/pathology , Adult , Cryptococcus/classification , Fatal Outcome , Female , Head/diagnostic imaging , Humans , Magnetic Resonance Imaging , Postpartum Period , Tomography, X-Ray Computed
9.
J Clin Pediatr Dent ; 39(3): 284-91, 2015.
Article in English | MEDLINE | ID: mdl-26208076

ABSTRACT

Despite the voluminous literature addressing the safety and efficacy of various sedative agents in the pediatric dental setting, the quality literature to form evidence based pediatric dental sedation practice is not available. Our search through PUBMED showed that during 1985-2012, a total of 184 original research papers on pediatric dental sedation were reported, and midazolam clearly dominated with 88 trials on this agent. Despite these large numbers of papers, Cochrane Review was able to pool a weak evidence in favor of midazolam. Data pooling from five heterogeneous high risk of bias trials showed that oral midazolam is associated with more cooperative behavior when compared to a placebo. Further, a very weak evidence regarding efficacy of nitrous oxide was collected from two trials, which could not be pooled. These findings draw attention to the need to address the shortcomings in the current state of pediatric dental sedation research. The present article has been focused on the current status of pediatric dental sedation research, and the limitations in the current research methodology. This paper also suggests recommendations for future research in the field of pediatric dental sedation.


Subject(s)
Anesthesia, Dental/methods , Conscious Sedation/methods , Dental Research , Hypnotics and Sedatives/administration & dosage , Pediatric Dentistry , Humans , Randomized Controlled Trials as Topic , Research Design
10.
Chem Soc Rev ; 44(20): 7128-54, 2015 Oct 21.
Article in English | MEDLINE | ID: mdl-26155855

ABSTRACT

The latest developments in zeolite membranes are reviewed, with an emphasis on the synthesis techniques, including seed assembly and secondary growth methods. This review also discusses the current industrial applications of zeolite membranes, the feasibility of their use in membrane reactors and their hydrothermal stability. Finally, zeolite membranes are compared with metal-organic framework (MOF) membranes and the latest advancements in MOF and mixed matrix membranes are highlighted.

11.
Eur Arch Paediatr Dent ; 16(6): 441-7, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26092507

ABSTRACT

AIM: To report on the prevalence, defect characteristics, and distribution of hypomineralised second primary molars (HSPM) in Gautam Budh Nagar, Uttar Pradesh, India and to report on possible association, if any, between HSPM and molar-incisor-hypomineralisation (MIH). METHODS: A cross-sectional survey included a random sample of 978, 6-8-year-old school children. EAPD diagnostic criteria for scoring MIH defects on first permanent molars (FPM) were adapted and used to score hypomineralisation defects in both FPM and second primary molars (SPM) by a single calibrated examiner. Comparative statistics for HSPM versus hypomineralised FPM were computed using a Chi square test. An odds ratio (OR) at 95 % confidence interval (CI) was used to test and any association between HSPM and MIH. RESULTS: An overall prevalence of 5.6 % (55/978) was reported for HSPM in the study population. Prevalence of MIH as hypomineralised FPM was 7.4 % (72/978). Concomitant presence of HSPM and MIH was observed in 32.73 % (18/55) of affected subjects. The presence of HSPM had significantly higher odds ratio for development of MIH (OR 7.82; 95 % CI = 4.18-14.65; p < 0.001). A greater severity of defects was observed in HSPM compared with affected FPM as greater number of affected surfaces presented with post-eruptive breakdown (PEB) in former compared to latter (p < 0.001). CONCLUSION: The prevalence of HSPM in 6-8-year-old Indian children was 5.6 %. The severity of hypomineralisation was milder in FPM compared to SPM. The presence of HSPM was reported to have significantly higher odds for development of MIH in future.


Subject(s)
Dental Enamel Hypoplasia/epidemiology , Molar/abnormalities , Tooth, Deciduous/abnormalities , Child , Cohort Studies , Cross-Sectional Studies , Female , Humans , India/epidemiology , Male , Prevalence
12.
Haemophilia ; 21(6): 806-11, 2015 Nov.
Article in English | MEDLINE | ID: mdl-25982122

ABSTRACT

UNLABELLED: von Willebrand disease (VWD), an inherited bleeding disorder caused by deficiency or dysfunction of von Willebrand factor (VWF) is diagnosed when a personal and often a family history of excessive mucocutaneous bleeding is present along with abnormal laboratory studies. An accurate assessment of haemorrhagic symptoms is key in suspecting VWD but presents a challenge especially in children due to overlap between normal and abnormal bleeding. Bleeding questionnaire (BQ) scores have been validated in adults and have recently been validated in children with VWD for assessing bleeding severity. However, there are limited data supporting their use prospectively in healthy children with bleeding complaints. AIM: The objectives of this study were to obtain normative data from children and validate a paediatric BQ (PBQ) to determine the discriminative ability of its total score and its individual components for identifying children likely to have VWD. METHODS: The PBQ was administered to 1281 multiethnic, healthy children between 30 days and 18 years of age presenting to a general paediatric office and to 35 children with VWD based on VWF antigen, activity and multimer pattern. RESULTS: When children with total BQ scores of 3 or more were predicted to have VWD, the sensitivity was 97.2%, the specificity was 97.1%, the positive predictive value was 48.6% and the negative predictive value was 99.9%. CONCLUSIONS: The PBQ may help discriminate a significant bleeding history from trivial bleeding, may be integrated into the primary care algorithm for evaluating children suspected with VWD.


Subject(s)
Healthy Volunteers , Hemorrhage/diagnosis , Mass Screening/statistics & numerical data , Surveys and Questionnaires/statistics & numerical data , von Willebrand Diseases/diagnosis , Adolescent , Adult , Child , Child, Preschool , Female , Hemorrhage/complications , Humans , Infant , Male , Reproducibility of Results , von Willebrand Diseases/complications
13.
Leukemia ; 29(3): 615-24, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25179730

ABSTRACT

FHL2, a member of the four and one half LIM domain protein family, is a critical transcriptional modulator. Here, we identify FHL2 as a critical regulator of hematopoietic stem cells (HSCs) that is essential for maintaining HSC self-renewal under regenerative stress. We find that Fhl2 loss has limited effects on hematopoiesis under homeostatic conditions. In contrast, Fhl2-null chimeric mice reconstituted with Fhl2-null bone marrow cells developed abnormal hematopoiesis with significantly reduced numbers of HSCs, hematopoietic progenitor cells (HPCs), red blood cells and platelets as well as hemoglobin levels. In addition, HSCs displayed a significantly reduced self-renewal capacity and were skewed toward myeloid lineage differentiation. We find that Fhl2 loss reduces both HSC quiescence and survival in response to regenerative stress, probably as a consequence of Fhl2-loss-mediated downregulation of cyclin-dependent kinase-inhibitors, including p21(Cip) and p27(Kip1). Interestingly, FHL2 is regulated under the control of a tissue-specific promoter in hematopoietic cells and it is downregulated by DNA hypermethylation in the leukemia cell line and primary leukemia cells. Furthermore, we find that downregulation of FHL2 frequently occurs in myelodysplastic syndrome and acute myeloid leukemia patients, raising a possibility that FHL2 downregulation has a role in the pathogenesis of myeloid malignancies.


Subject(s)
Bone Marrow Transplantation , Gene Expression Regulation , LIM-Homeodomain Proteins/genetics , Leukemia, Myeloid, Acute/genetics , Muscle Proteins/genetics , Myelodysplastic Syndromes/genetics , Transcription Factors/genetics , Animals , Bone Marrow Cells/metabolism , Bone Marrow Cells/pathology , Cell Proliferation , Cyclin-Dependent Kinase Inhibitor p21/genetics , Cyclin-Dependent Kinase Inhibitor p21/metabolism , Cyclin-Dependent Kinase Inhibitor p27/genetics , Cyclin-Dependent Kinase Inhibitor p27/metabolism , DNA Methylation , Hematopoiesis , Hematopoietic Stem Cells/metabolism , Hematopoietic Stem Cells/pathology , Humans , LIM-Homeodomain Proteins/deficiency , LIM-Homeodomain Proteins/metabolism , Leukemia, Myeloid, Acute/metabolism , Leukemia, Myeloid, Acute/pathology , Mice , Mice, Knockout , Muscle Proteins/deficiency , Muscle Proteins/metabolism , Myelodysplastic Syndromes/metabolism , Myelodysplastic Syndromes/pathology , Promoter Regions, Genetic , Signal Transduction , Stress, Physiological , Transcription Factors/deficiency , Transcription Factors/metabolism , Transplantation, Isogeneic , Whole-Body Irradiation
14.
J Environ Manage ; 146: 107-115, 2014 Dec 15.
Article in English | MEDLINE | ID: mdl-25163601

ABSTRACT

In order to develop climate resilient urban areas and reduce emissions, several opportunities exist starting from conscious planning and design of green (and blue) spaces in these landscapes. Green urban infrastructure has been regarded as beneficial, e.g. by balancing water flows, providing thermal comfort. This article explores the existing evidence on the contribution of green spaces to climate change mitigation and adaptation services. We suggest a framework of ecosystem services for systematizing the evidence on the provision of bio-physical benefits (e.g. CO2 sequestration) as well as social and psychological benefits (e.g. improved health) that enable coping with (adaptation) or reducing the adverse effects (mitigation) of climate change. The multi-functional and multi-scale nature of green urban infrastructure complicates the categorization of services and benefits, since in reality the interactions between various benefits are manifold and appear on different scales. We will show the relevance of the benefits from green urban infrastructures on three spatial scales (i.e. city, neighborhood and site specific scales). We will further report on co-benefits and trade-offs between the various services indicating that a benefit could in turn be detrimental in relation to other functions. The manuscript identifies avenues for further research on the role of green urban infrastructure, in different types of cities, climates and social contexts. Our systematic understanding of the bio-physical and social processes defining various services allows targeting stressors that may hamper the provision of green urban infrastructure services in individual behavior as well as in wider planning and environmental management in urban areas.


Subject(s)
Cities , Climate Change , Ecosystem , City Planning , Ecological and Environmental Phenomena , Environment Design , Humans , Urban Health
15.
Malar Res Treat ; 2014: 372521, 2014.
Article in English | MEDLINE | ID: mdl-24800100

ABSTRACT

Background. CDRI 97/78 has shown efficacy in animal models of falciparum malaria. The present study is the first in-human phase I trial in healthy volunteers. Methods. The study was conducted in 50 healthy volunteers in a single, ascending dose, randomized, placebo-controlled, double blind design. The dose ranges evaluated were from 80 mg to 700 mg. Volunteers were assessed for clinical, biochemical, haematological, radiographic, and electrocardiographic parameters for any adverse events in an in-house facility. After evaluation of safety study results, another cohort of 16 participants were administered a single oral dose of 200 mg of the drug and a detailed pharmacokinetic analysis was undertaken. Results. The compound was found to be well tolerated. MTD was not reached. The few adverse events noted were of grade 2 severity, not requiring intervention and not showing any dose response relationship. The laboratory and electrocardiographic parameters showed statistically significant differences, but all were within the predefined normal range. These parameters were not associated with symptoms/signs and hence regarded as clinically irrelevant. Mean values of T 1/2, MRT, and AUC0-∞ of the active metabolite 97/63 were 11.85 ± 1.94 h, 13.77 ± 2.05 h, and 878.74 ± 133.15 ng·h/mL, respectively Conclusion. The novel 1,2,4 trioxane CDRI 97/78 is safe and will be an asset in malarial therapy if results are replicated in multiple dose studies and benefit is shown in confirmatory trials.

16.
Eur Arch Paediatr Dent ; 15(1): 11-8, 2014 Feb.
Article in English | MEDLINE | ID: mdl-23754204

ABSTRACT

UNLABELLED: There is rarity of prevalence data on molar incisor hypomineralisation (MIH) for the Indian population and the majority of data originated from European countries. AIM: To report on prevalence and defect characteristics of MIH for school children of the northern Indian region. METHODS: A cross-sectional survey including 1,792, 6-9-year-old school children of Chandigarh, India was carried out using European Academy of Paediatric Dentistry (EAPD) 2003 criteria for diagnosis of MIH. In addition to descriptive analysis for distribution of various defects, comparative data analysis was carried out for inter-comparison of distribution and type of defect amongst two phenotypes, MH [first permanent molar (FPMs) involvement] and M + IH (simultaneous involvement of molars and incisors). Similar comparative analysis was performed for four subgroups on the basis of number of affected surfaces/subjects. RESULTS: A prevalence of 6.31% was reported. FPMs (2.83 ± 0.874/subject) were more commonly affected than permanent incisors (1.19 ± 1.614/subjects). White/creamy opacity without post-eruptive breakdown (PEB) was the most common lesion, seen in 85% of subjects. MH phenotype was seen in 44% of subjects and 56% exhibited M + IH phenotype. A trend toward greater severity was seen in M + IH phenotype when compared to MH phenotype. A greater number of surfaces presented with white/creamy opacities without PEB (p < 0.05). With an increase in the number of surfaces involved the severity of MIH also increased with more frequent presence of brown defects with PEB. CONCLUSION: With concomitant involvement of incisors, more severe presentation of MIH was seen. Also, with increase in number of affected surfaces a parallel increase in severity as well as extent of lesions was observed.


Subject(s)
Dental Enamel Hypoplasia/epidemiology , Child , Cohort Studies , Cross-Sectional Studies , Dental Enamel/abnormalities , Dental Enamel Hypoplasia/classification , Dental Restoration, Permanent/statistics & numerical data , Female , Humans , Incisor/pathology , India/epidemiology , Male , Molar/pathology , Phenotype , Prevalence
17.
Minerva Stomatol ; 62(9): 343-8, 2013 Sep.
Article in English | MEDLINE | ID: mdl-24126600

ABSTRACT

Central giant cell granuloma (CGCG) is a benign, non-odontogenic bone lesion of jaw. The condition is relatively infrequent and affects mainly children and young adults with a certain predominance among females and exhibits variable aggressiveness. Giant cell lesion associated with hyperparathyroidism is known as Brown tumor. Brown tumor is one of the bony complications of hyperparathyroidism. It is a giant cell granuloma which occurs in osteitis fibrosis cystica. It represents the terminal stage of the bone remodelling processes occurring as a result of peritrabecular fibrosis and osteoclastic activity. The mandible is the predominantly affected site in the maxillofacial area. Maxillary involvement is rare. The incidence of Brown tumor associated with hyperparathyroidism is rare (0.1%). Here, an extremely rare case of a 20 year old female patient with Brown tumor in her maxilla and mandible associated with primary hyperparathyroidism was presented. A thorough diagnostic work up showed presence of tumor mass in mandible and maxilla and elevated serum alkaline phosphatase and parathormone level and the patient was treated for both hyperparathyroidism and Brown tumor were discussed. The importance of different radiological evaluation methods and the consultation between the oral and maxillofacial surgeons, dentists, endocrinologists and radiologists were emphasized.


Subject(s)
Granuloma, Giant Cell/diagnosis , Hyperparathyroidism, Primary/complications , Mandibular Diseases/diagnosis , Maxillary Diseases/diagnosis , Diagnosis, Differential , Early Diagnosis , Female , Granuloma, Giant Cell/etiology , Granuloma, Giant Cell/surgery , Humans , Hyperparathyroidism, Primary/diagnostic imaging , Hyperparathyroidism, Primary/surgery , Hyperplasia , Jaw Neoplasms/diagnosis , Mandibular Diseases/etiology , Maxillary Diseases/etiology , Osteoclasts/pathology , Parathyroid Glands/diagnostic imaging , Parathyroid Glands/pathology , Parathyroidectomy , Radionuclide Imaging , Young Adult
18.
J Clin Pediatr Dent ; 37(4): 415-20, 2013.
Article in English | MEDLINE | ID: mdl-24046993

ABSTRACT

OBJECTIVE: To find out the safe and efficient sedative agent for primary molar pulpectomy in uncooperative pediatric patients. STUDY DESIGN: This double blind randomized trial enrolled 40 anxious and healthy 2-6 year olds. All subjects received IV propofol (1-1.5 mg/kg) or ketofol (1-1.5 mg/kg propofol with 0.25 mg/kg ketamine) as per group assignment after oral midazolam premedication (0.5 mg/kg). Sedation maintenance was done with propofol infusion at 25-75 microg/kg/min titrated to a predefined Worse level as per Houpt's sedation rating scale. Additional bolus/es was/were administered in the dosage similar to induction dose in case of inadequate sedation. Primary outcomes were intraoperative and postoperative adverse events. Secondary outcomes were vital signs, success of procedure, operator satisfaction, sedation quality, treatment time, recovery time and total propofol dose. RESULTS: Significantly greater incidence of respiratory depression was reported for ketofol group (11/20; 55%) when compared to propofol group (3/20; 15%) (p = 0.008). Desaturation was the most common adverse respiratory event with significantly greater incidence in ketofol group (9/20; 45%) when compared to propofol only group (3/20; 15%) (p = 0.033). No significant differences regarding secondary outcomes were reported in two groups. CONCLUSION: Both the regimen exhibited similar sedation profile while propofol alone emerged as a safer option.


Subject(s)
Dental Anxiety/drug therapy , Hypnotics and Sedatives/adverse effects , Ketamine/adverse effects , Propofol/adverse effects , Respiratory Insufficiency/chemically induced , Child , Child, Preschool , Double-Blind Method , Drug Combinations , Female , Humans , Male , Midazolam/therapeutic use , Pulpectomy
19.
Indian J Cancer ; 50(3): 261-7, 2013.
Article in English | MEDLINE | ID: mdl-24061469

ABSTRACT

BACKGROUND: The present study of 238 B-cell Chronic Lymphocytic Leukemia (B-CLL) patients were undertaken to seek the prevalence and to evaluate clinico-pathological significance of recurrent genetic abnormalities such as del(13q14.3), trisomy 12, del(11q22.3) (ATM), TP53 deletion, del(6q21) and IgH translocation/deletion. MATERIALS AND METHODS: We applied interphase - fluorescence in situ hybridization (FISH) on total 238 cases of B-CLL. RESULTS: Our study disclosed 69% of patients with genetic aberrations such as 13q deletion (63%), trisomy 12 (28%), 11q deletion (18%), 6q21 deletion (11%) with comparatively higher frequency of TP53 deletion (22%). Deletion 13q displayed as a most frequent sole abnormality. In group with coexistence of ≥2 aberrations, 13q deletion was a major clone indicating del(13q) as a primary event followed by 11q deletion, TP53 deletion, trisomy 12, 6q deletion as secondary progressive events. In comparison with del(13q), trisomy 12, group with coexistence of ≥2 aberrations associated with poor risk factors such as hyperleukocytosis, advanced stage, and multiple nodes involvement. In a separate study of 116 patients, analysis of IgH abnormalities revealed either partial deletion (24%) or translocation (5%) and were associated with del(13q), trisomy 12, TP53 and ATM deletion. Two of 7 cases had t(14;18), one case had t(8;14), and four cases had other variant IgH translocation t(?;14). CONCLUSION: Detail characterization and clinical impact are necessary to ensure that IgH translocation positive CLL is a distinct pathological entity. Our data suggests that CLL with various cytogenetic subsets, group with coexistence of ≥2 aberrations seems to be a complex cytogenetic subset, needs more attention to understand biological significance and to seek clinical impact for better management of disease.


Subject(s)
Chromosome Aberrations , Leukemia, Lymphocytic, Chronic, B-Cell/genetics , Leukemia, Lymphocytic, Chronic, B-Cell/pathology , Adult , Aged , Aged, 80 and over , Female , Humans , In Situ Hybridization, Fluorescence , India , Male , Middle Aged , Young Adult
20.
J Laryngol Otol ; 127 Suppl 2: S54-6, 2013 Jul.
Article in English | MEDLINE | ID: mdl-23575347

ABSTRACT

OBJECTIVE: Laryngeal cryptococcosis is a rare condition. In this report, we describe the findings for and treatment of a 58-year-old man with Cryptococcus gattii infection of the right vocal fold. METHOD: Case report and review of the relevant English language literature. RESULTS: The patient presented with persistent hoarseness of voice. Laryngoscopy demonstrated an irregular, red lesion on the right vocal fold. Histopathological examination identified cryptococcus. The patient was treated with oral fluconazole 400 mg/day for eight weeks. CONCLUSION: Laryngeal involvement by Cryptococcus gattii can result from prolonged inhaled corticosteroid therapy and proximity to eucalyptus trees. The clinical presentation, laryngoscopic findings and imaging results of laryngeal involvement may mimic a neoplasm. Histopathological examination can demonstrate the causative organism. Management consists of advice from an infectious disease specialist together with adequate treatment by antifungal agents.


Subject(s)
Antifungal Agents/therapeutic use , Cryptococcosis/diagnosis , Cryptococcus gattii , Fluconazole/therapeutic use , Laryngeal Diseases/diagnosis , Adrenal Cortex Hormones/adverse effects , Cryptococcosis/drug therapy , Diagnosis, Differential , Eucalyptus/adverse effects , Hoarseness/drug therapy , Hoarseness/microbiology , Humans , Inhalation Exposure/adverse effects , Laryngeal Diseases/drug therapy , Male , Middle Aged , Rare Diseases , Vocal Cords , Voice
SELECTION OF CITATIONS
SEARCH DETAIL
...